Showing results (181-190 of 246) with videos related to
Sort By:
Pageof 25
International Journal of Clinical Oncology|September 23, 2019
Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II)Norifumi Hattori, Goro Nakayama, Keisuke Uehara, et al.World Journal of Surgery|November 1, 2018
Intraoperative Blood Loss is Associated with Shortened Postoperative Survival of Patients with Stage II/III Gastric Cancer: Analysis of a Multi-institutional DatasetYuki Ito, Mitsuro Kanda, Seiji Ito, et al.Anticancer Research|April 3, 2020
Exploration of Exosomal Micro RNA Biomarkers Related to Epithelial-to-Mesenchymal Transition in Pancreatic CancerFuminori Sonohara, Suguru Yamada, Shigeomi Takeda, et al.International Journal of Oncology|November 19, 2014
B‑cell translocation gene 1 serves as a novel prognostic indicator of hepatocellular carcinomaMitsuro Kanda, Hiroyuki Sugimoto, Shuji Nomoto, et al.Oncotarget|February 13, 2016
Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancerMitsuro Kanda, Dai Shimizu, Haruyoshi Tanaka, et al.Annals of Surgical Oncology|August 21, 2015
The Prognostic Relevance of Subcarinal Lymph Node Dissection in Esophageal Squamous Cell CarcinomaYukiko Niwa, Masahiko Koike, Masashi Hattori, et al.Surgery Today|August 26, 2021
Prognostic impact of a microscopic positive margin in patients undergoing gastrectomy for gastric cancer: a propensity score‑matched analysis of a multi‑institutional datasetKoki Nakanishi, Mitsuro Kanda, Seiji Ito, et al.Surgery Today|June 29, 2022
Preoperative neutrophil-to-platelet ratio as a potential prognostic factor for gastric cancer with positive peritoneal lavage cytology in the absence of other non-curative factors: a multi-institutional dataset analysisAkira Nonogaki, Mitsuro Kanda, Seiji Ito, et al.International Journal of Oncology|September 6, 2014
Clinical utility of PDSS2 expression to stratify patients at risk for recurrence of hepatocellular carcinomaMitsuro Kanda, Hiroyuki Sugimoto, Shuji Nomoto, et al.Journal of Gastroenterology|September 1, 2014
Dihydropyrimidinase-like 3 is a putative hepatocellular carcinoma tumor suppressorHisaharu Oya, Mitsuro Kanda, Hiroyuki Sugimoto, et al.Pageof 25